	US 12,250,949 B2
	Formulations with colloidal silver
Nathan R. Moeller, Highland, UT (US); Sheree M. Moeller, Highland, UT (US); Jerry S. Revelli, Highland, UT (US); and Robert J. Holladay, Saratoga Springs, UT (US)
Assigned to American Silver, LLC, American Fork, UT (US)
Filed by AMERICAN SILVER, LLC, American Fork, UT (US)
Filed on Jan. 22, 2023, as Appl. No. 18/099,953.
Application 18/099,953 is a continuation of application No. 17/065,186, filed on Oct. 7, 2020, granted, now 11,564,395.
Application 17/065,186 is a continuation of application No. 15/753,289, abandoned, previously published as PCT/US2016/047649, filed on Aug. 18, 2016.
Claims priority of provisional application 62/206,681, filed on Aug. 18, 2015.
Prior Publication US 2023/0255210 A1, Aug. 17, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 59/16 (2006.01); A61K 8/04 (2006.01); A61K 8/19 (2006.01); A61K 8/27 (2006.01); A61K 31/60 (2006.01); A61K 33/38 (2006.01); A61Q 17/04 (2006.01)

CPC A01N 59/16 (2013.01) [A61K 8/044 (2013.01); A61K 8/19 (2013.01); A61K 8/27 (2013.01); A61K 31/60 (2013.01); A61K 33/38 (2013.01); A61Q 17/04 (2013.01)]

2 Claims

1. A skin care formulation, the formulation in a form of a serum, the formulation comprising colloidal silver particles at a concentration of 20±5 ppm, water, glycerin, hyaluronic acid at a concentration of 0.25 wt % to 2.5 wt %, the hyaluronic acid comprising a first hyaluronic acid polymer having a first weight average molecular weight of about 12 thousand Daltons and a second hyaluronic acid having a second weight average molecular weight of about 1,100 thousand Daltons.